Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Investing.com - West Pharmaceutical Services (NYSE: WST) reported first quarter EPS of $1.45, $0.22 better than the analyst estimate of $1.23. Revenue for the quarter came in at $698M versus the consensus estimate of $684.94M.
Guidance
West Pharmaceutical Services sees FY 2025 EPS of $6.15-$6.35 versus the analyst consensus of $7.02.
West Pharmaceutical Services sees FY 2025 revenue of $2.95B-$2.98B versus the analyst consensus of $3.09B.
West Pharmaceutical Services’s stock price closed at $218.18. It is down -36.76% in the last 3 months and down -40.74% in the last 12 months.
West Pharmaceutical Services saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See West Pharmaceutical Services’s stock price’s past reactions to earnings here.
According to InvestingPro, West Pharmaceutical Services’s Financial Health score is "good performance".
Check out West Pharmaceutical Services’s recent earnings performance, and West Pharmaceutical Services’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar